Lifestyle for Environment (LiFE): a global initiative to fight against climate change through community engagement and lifestyle modification [0.03%]
《低碳生活 全民行动》
Khaiwal Ravindra,Akshi Goyal,Suman Mor
Khaiwal Ravindra
Comparing barriers and enablers of women's health leadership in India with East Africa and North America [0.03%]
印度妇女卫生领导力障碍与促进因素与东非及北美的比较研究
Shagun Sabarwal,Jade Lamb,Shereen Bhan et al.
Shagun Sabarwal et al.
Background: Women are estimated to hold between 70 and 75% of global health positions worldwide yet persistent inequities in power and leadership remain. There is little information on specific enablers and barriers that ...
Predictors and disparities in neonatal and under 5 mortality in rural Pakistan: cross sectional analysis [0.03%]
巴基斯坦农村婴儿及五岁以下儿童死亡率的预测因素及不平等现象：横断面分析
Zahid Memon,Daniel Fridman,Sajid Soofi et al.
Zahid Memon et al.
Background: Adopted in 2015, the sustainable development goals (SDGs) have set specific targets (SDG 3.2) for countries to reduce their neonatal mortality rate (NMR) to below 12 deaths per 1000 live births and under 5 mor...
Ashna Biju
Ashna Biju
The UN projects that India is now the world's most populous nation. However, with this rising population comes a significant need for safer period product disposal systems. Current practices include local incineration or burial of sanitary ...
Prevalence and determinants of delays in care among premature deaths due to acute cardiac conditions and stroke in residents of a district in India [0.03%]
印度一地区急性心脏疾病和卒中死亡病例的治疗延迟及其影响因素研究
Anand Krishnan,Md Asadullah,Rakesh Kumar et al.
Anand Krishnan et al.
Background: Lack of timely care is a predictor of poor outcomes in acute cardiovascular emergencies including stroke. We assessed the presence of delay in seeking appropriate care among those who died due to cardiac/strok...
Heart disease complicating pregnancy as a leading cause of maternal deaths in LMIC settings: the Sri Lankan experience [0.03%]
发展中国家妊娠期心脏病导致产妇死亡的主要原因：斯里兰卡的经验
Ayesh Hettiarachchi,Kapila Jayaratne,Chithramalee De Silva et al.
Ayesh Hettiarachchi et al.
Background: Heart disease (HD) is one of the leading indirect causes of maternal deaths worldwide, both in high- and low- and middle-income countries (LMICs). This study aims to describe maternal deaths due to cardiovascu...
Impact of diarrhoea and acute respiratory infection on environmental enteric dysfunction and growth of malnourished children in Pakistan: a longitudinal cohort study [0.03%]
腹泻和急性呼吸道感染对巴基斯坦营养不良儿童环境性肠病及生长的影响：纵向队列研究
Azza Sarfraz,Zehra Jamil,Sheraz Ahmed et al.
Azza Sarfraz et al.
Background: Diarrhoea and acute respiratory infections (ARI) are assumed to be major drivers of growth and likely contribute to environmental enteric dysfunction (EED), which is a precursor to childhood malnutrition. In t...
Normative range of various serum hormonal parameters among Indian women of reproductive age: ICMR-PCOS task force study outcome [0.03%]
印度生育年龄女性各种血清激素参数的规范范围：ICMR-PCOS 任务组研究结果
Mohd Ashraf Ganie,Subhankar Chowdhury,Vanita Suri et al.
Mohd Ashraf Ganie et al.
Background: The hormonal profile varies considerably with age, gender, ethnicity, diet or physiological state of an individual. Limited population-specific studies have studied the variations in hormonal parameters among ...
Predicting the dengue cluster outbreak dynamics in Yogyakarta, Indonesia: a modelling study [0.03%]
印度尼西亚日惹登革热疫情簇群暴发的动态预测：一项建模研究
Aditya Lia Ramadona,Yesim Tozan,Jonas Wallin et al.
Aditya Lia Ramadona et al.
Background: Human mobility and climate conditions are recognised key drivers of dengue transmission, but their combined and individual role in the local spatiotemporal clustering of dengue cases is not well understood. Th...
Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice [0.03%]
塞来西匹/阿维巴坦在中低收入国家失去市场独占权：对抗菌药物管理实践的考验
Balaji Veeraraghavan,Yamuna Devi Bakthavatchalam,Rani Diana Sahni et al.
Balaji Veeraraghavan et al.
Ceftazidime/avibactam is a last-line antibiotic, to be used as a targeted therapy for certain carbapenem-resistant Gram-negative infections and not to be used as an empirical therapy or as a carbapenem-sparing therapy. After a span of 5 yea...